Is heparin an acceptable anticoagulant when glycoprotein IIb/IIIa inhibitors are not used?

Michael S. Lee; Seung Woon Rha; Kyung Woo Park; Moo Hyun Kim

doi:10.1016/j.jcin.2014.07.019

Is heparin an acceptable anticoagulant when glycoprotein IIb/IIIa inhibitors are not used?

Michael S. Lee, Seung Woon Rha, Kyung Woo Park, Moo Hyun Kim

Department of Biomedical Sciences

Research output: Contribution to journal › Review article › peer-review

Original language	English
Pages (from-to)	223-224
Number of pages	2
Journal	JACC: Cardiovascular Interventions
Volume	8
Issue number	1
DOIs	https://doi.org/10.1016/j.jcin.2014.07.019
Publication status	Published - 2015 Jan 1

Keywords

Bivalirudin
Coronary artery disease
Heparin
Percutaneous coronary intervention

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.jcin.2014.07.019

Cite this

@article{2961898d02c44b3fb041598348a4e316,

title = "Is heparin an acceptable anticoagulant when glycoprotein IIb/IIIa inhibitors are not used?",

keywords = "Bivalirudin, Coronary artery disease, Heparin, Percutaneous coronary intervention",

author = "Lee, {Michael S.} and Rha, {Seung Woon} and Park, {Kyung Woo} and Kim, {Moo Hyun}",

year = "2015",

month = jan,

day = "1",

doi = "10.1016/j.jcin.2014.07.019",

language = "English",

volume = "8",

pages = "223--224",

journal = "JACC: Cardiovascular Interventions",

issn = "1936-8798",